Wednesday, August 21, 2024

Existential Confusion: America on psychedelics

"Existential confusion" is frequently said to be a possible negative side effect of psychedelic drugs. I think the phrase mostly means you are suddenly uncertain about who you are, where you are, what's real, what you're doing in the world and why.

Psychiatrists intentionally confuse their patients about who they are, where they are, what's real, what they're doing in the world and why. It's seen as a fundamental method to control people (e.g., gaslighting), and psychiatric patients are believed to be in great need of control, because they threaten and offend others. Hence, psychedelic drugs would seem to be a natural "treatment" in psychiatry.

The irony is that psychedelic drugs will ruin psychiatry utterly. Confusion is the antithesis of control, because it doesn't merely cause a person whose actions others don't like to become less active and therefore less trouble. The anatomy of control is start, change, and stop. (If you can start, change and stop something at will, you control that thing.) Psychedelics render a person unable to start, change, or stop anything, especially his/her own mind. I have written that the essence of these drugs is best expressed in two words: NO CONTROL!

One of the three biggest problems the FDA recently had with the research behind Lycos' MDMA application was "placebo unblinding," which meant there was NO CONTROL (group).

The facilitators in some instances crossed boundaries and abused patients during trials. There was evidently NO CONTROL of sexuality. (Perfect for the psychiatric slave plantations in Illinois, by the way!)

I have heard a former President of the American Psychiatric Association predict that the moment a psychedelic drug is approved to treat mental disorder, there will be NO CONTROL of the quality or supply of the drug; rapidly exploding demand will (as with the ongoing example of Ketamine) assure that regulators will have NO CONTROL over street (non-clinical) use.

Now that Rick Doblin's bucket-list life ambition, of FDA approval for MDMA-assisted psychotherapy to treat PTSD is thoroughly shot down, the next plan will be psilocybin for depression. Two bio-tech companies, Compass Pathways and Usona Institute are already in Phase 3 trials. Right behind them, Mindmed is in a Phase 2b trial of LSD for anxiety(!) and atai Life Sciences is working on DMT for depression. Approval of any psychedelic drug to treat mental disorder will replay the Ketamine disaster. Hundreds of "clinics" will spring up overnight, the drug will be everywhere. But collateral damage from psilocybin alone will be many times what Ketamine is causing, and LSD will dwarf all previous negative impacts put together. 

Anyone who wants a taste of what "America on psychedelics" may look like should watch a YouTube video of an interview of two supposed proponents of medical psychedelic drugs. They both seem so existentially and ardently confused that neither even knows the other may be an ally, and apparently presumes anyone encountered must be an enemy. They don't know what their own positions even are, or why they should argue with anyone. It's worse than the current national political scene, and it's the last thing this society needs right now!

We all need to walk around, get our bearings, look at real walls and touch them, not hallucinate that the walls are breathing, not conjure the interdimensional demons. Psychotomimetics are not vitamins.

Willie Nelson sings, "The world's gone crazy and it seems to get worse every day, so come on back Jesus, and pick up John Wayne on the way."

Plasticine porters with looking glass ties, the girl with kaleidoscope eyes, invite insanity.

2 comments:

  1. This is Getulio Valino (Jun), I didn't see you today. Dr. Malis was right, you are a loser. No wonder he reported you to the ARDC

    ReplyDelete
    Replies
    1. Sorry I missed you, Getulio!
      Do you realize the benefit Dr. Malis-with-malice got by reporting me to the ARDC?

      Delete